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Abstract
Background: The potential for adverse respiratory effects following exposure to electronic (e-) cigarette liquid (e-liquid)
flavorings remains largely unexplored. Given the multitude of flavor permutations on the market, identification of those
flavor constituents that negatively impact the respiratory tract is a daunting task. In this study we examined the impact
of common e-liquid flavoring chemicals on the airway epithelium, the cellular monolayer that provides the first line of
defense against inhaled particulates, pathogens, and toxicants.
Methods: We used the xCELLigence real-time cell analyzer (RTCA) as a primary high-capacity screening tool to assess
cytotoxicity thresholds and physiological effects of common e-liquid flavoring chemicals on immortalized human
bronchial epithelial cells (16HBE14o-). The RTCA was used secondarily to assess the capability of 16HBE14o- cells to
respond to cellular signaling agonists following a 24 h exposure to select flavoring chemicals. Finally, we conducted
biophysical measurements of well-differentiated primary mouse tracheal epithelial (MTE) cells with an Ussing chamber
to measure the effects of e-cigarette flavoring constituents on barrier function and ion conductance.
Results: In our high-capacity screens five of the seven flavoring chemicals displayed changes in cellular impedance
consistent with cell death at concentrations found in e-liquid. Vanillin and the chocolate flavoring 2,5-dimethylpyrazine
caused alterations in cellular physiology indicative of a cellular signaling event. At subcytotoxic levels, 24 h exposure to
2,5-dimethylpyrazine compromised the ability of airway epithelial cells to respond to signaling agonists important in
salt and water balance at the airway surface. Biophysical measurements of 2,5-dimethylpyrazine on primary MTE cells
revealed alterations in ion conductance consistent with an efflux at the apical airway surface that was accompanied
by a transient loss in transepithelial resistance. Mechanistic studies confirmed that the increases in ion conductance
evoked by 2,5-dimethylpyrazine were largely attributed to a protein kinase A-dependent (PKA) activation of the cystic
fibrosis transmembrane conductance regulator (CFTR) ion channel.
Conclusions: Data from our high-capacity screening assays demonstrates that individual e-cigarette liquid flavoring
chemicals vary in their cytotoxicity profiles and that some constituents evoke a cellular physiological response on their
own independent of cell death. The activation of CFTR by 2,5-dimethylpyrazine may have detrimental consequences
for airway surface liquid homeostasis in individuals that use e-cigarettes habitually.
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Background
Electronic (e-) cigarettes are the most common type of
electronic nicotine delivery systems (ENDS) that simu-
late smoking independent of the combustion of tobacco.
The global market for ENDS has rapidly expanded and
it is predicted that within the next decade, sales of ENDS
will surpass that of conventional combustible tobacco
cigarettes [1]. In the U.S. market alone e-cigarette
sales are estimated to be $10 billion by 2017 [2]. As
of 2014 there were >450 distinct e-cigarette products
with >7500 flavor variations available for sale online
and/or at retail outlets worldwide [3–6]. Despite the
rapid increase in popularity of ENDS the potential
for harmful respiratory effects following use of these
products remains largely unexplored.
In their simplest form e-cigarettes contain a fluid-filled
(e-liquid) cartridge with a battery-powered atomizer.
E-liquid comes in a vast variety of configurations and
can contain numerous ingredients including vegetable
glycerin (VG) responsible for the visible vapor, the humec-
tant propylene glycol (PG), nicotine, menthol and/or other
flavorings. Although an early study of e-cigarettes sug-
gested that the levels of several harmful constituents
are lower in e-cigarette aerosols when compared with
cigarette smoke [7], some constituents unique to e-
cigarette aerosols, namely flavorings, have been shown
to be cytotoxic in cell models [8].
Research in to the composition and concentration of
flavorings in e-liquids is just beginning [9–11]. E-liquid
flavorings are often advertised as “safe” because they are
approved for ingestion. However, the airway and the
gastrointestinal tract are quite distinct and represent sig-
nificantly different toxicity susceptibilities. A cautionary
example that illustrates this point is the toxicity fate of
diacetyl, an early component of artificial butter popcorn
flavoring. Despite being approved for ingestion, excessive
inhalation exposure of diacetyl to lung tissue results in
bronchiolitis obliterans, a rare and irreversible lung dis-
ease [12]. The potential for e-liquid flavoring chemicals
to cause detrimental health effects warrants their investi-
gation [13].
The conducting airway epithelium provides the first
line of defense against inhaled particulates, pathogens,
allergens, and other noxious agents [14]. The varied
epithelial cell types along the conducting airway pro-
vide key innate immune functions including: a physical
barrier to protect the underlying tissue; salt and water
movement to maintain a hydrated lumen; a mucociliary
escalator to coordinate particulate filtering; and secre-
tion of multiple defense factors such as antimicrobials.
These functions of airway epithelial innate immunity
are facilitated by signal transduction molecules such as
ATP and cAMP. A compromised airway epithelium can
lead to infection, inflammation and airway remodeling
associated with the onset and pathogenesis of chronic
lung disease (reviewed in [15–19]). Because e-cigarette
aerosols are delivered directly to the airway a logical
place to initiate toxicity studies is with airway epithelial
cell models.
In this study we used high-capacity real-time cell
analysis as a primary screen to identify toxicity thresh-
olds of e-liquid flavorings on human bronchial epithe-
lial cells (16HBE14o-). Because cells can contribute to
disease in lieu of cell death, we also used high-capacity
real-time cell analysis to measure responses to cellular
signaling molecules (i.e., ATP and forskolin-induced
cAMP) following exposure to subcytotoxic levels of
e-liquid flavoring chemicals. From the cytotoxic and
subcytotoxic profiles established, we selected 2,5-
dimethylpyrazine for more thorough mechanistic studies.
From biophysical analyses we showed a direct effect of
2,5-dimethylpyrazine on the regulation of Cl- secretion.
These findings confirm the need for high-capacity
toxicity screening that can lead to mechanistic under-
standing to better predict risks associated with the
rapidly growing e-cigarette products.
Methods
Materials
Cellgro DMEM:F12 was from Mediatech (Manassas,
VA). Lechner and LaVeck basal media (LHC), Hanks’
Balanced Saline Solution, glutamax, penicillin, and
streptomycin were from Life Technologies (Carlsbad,
CA). Fibronectin, type I collagen, and Nu-Serum™ were
from Becton-Dickinson (Franklin Lakes, NJ). Minimum
Essential Medium with Earle’s salts (MEM), Fetal Bo-
vine Serum (FBS), 2,5-dimethylpyrazine, amiloride,
damascenone, forskolin, linalool, α-ionone, ethyl mal-
tol, furaneol and vanillin were from Sigma-Aldrich (St.
Louis, MO). CFTR-172 inh and 8-bromo-cAMP were
from Tocris Bioscience (Bristol, UK). Semipermeable
filters were Corning Costar 6.5 mm Transwell® with
0.4 μm Pore Polyester Membrane Insert, sterile (Lowell,
MA). All other chemicals were from Sigma-Aldrich or
Fisher Scientific (Pittsburgh, PA).
Immortalized human bronchial epithelial cell culture
methods
16HBE14o- cells, a SV40 transformed human bronchial
epithelial cell line [20], were obtained through the
California Pacific Medical Center Research Institute (San
Francisco, CA, USA). Growth conditions for 16HBE14o-
cells have been described [21, 22]. 16HBE14o- cells were
grown on a collagen/fibronectin/BSA (CFB) matrix. Cells
were expanded in flasks and passaged onto E-plates
(ACEA Biosciences, San Diego, CA) at 40,000 cells per
well for high-capacity real-time cell analysis.
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Primary Mouse Tracheal Epithelial (MTE) cell culture
methods
Animal protocols were approved by the Institutional
Animal Care and Use Committee of The University of
Arizona. Primary MTE cells were chosen for Ussing
chamber studies because they are representative of a
polarized epithelium necessary for biophysical measure-
ments. C57Bl/6 wild type mice were used for these cells
that were cultured as previously described [23]. MTE
cells were seeded onto 6.5 mm semipermeable filters
coated with CFB matrix and cultured at 37 °C with 5 %
CO2. After cell monolayers reached a transepithelial re-
sistance of > 500 Ω ⋅ cm2 (~5 days) the apical media was
removed to establish an air/liquid interface (ALI). These
cells become a mixed population of well-differentiated
cells with clearly established cilia after ~ 5 days at ALI.
Cells were used for experimentation 2–3 weeks after dif-
ferentiation was established.
xCELLigence real time cell analyzer toxicity and cell
signaling assays
Methods for high-capacity real-time cell analysis of
toxicity and physiological responses have been described
[21, 24] and the measurement of cytotoxicity validated
in 16HBE14o- cells [25]. 16HBE14o- cells were plated in
full culture medium onto 96 well E-plates coated with
CFB solution and allowed to grow at 37 °C and 5 % CO2
while impedance at the well surface was continuously
monitored [26, 27]. As per manufacturer’s instructions
(ACEA Biosciences, San Diego, CA), relative impedance
is expressed as a Cell Index where: Cell Index = (Zi-Z0)/
15Ω; and Zi is impedance at a given time point during
the experiment (i.e., post ATP addition), and Z0 is im-
pedance before the addition of agonist. For reference, a
dramatic decrease in impedance can be indicative of cell
death whereas activation of GPCR/Gq, such as occurs
following ATP activation of purinergic receptors, results
in an increase in Cell Index [21]. To determine toxicity
thresholds cells were grown overnight on an E-plate and
then exposed to varying doses of e-liquid flavoring
chemicals diluted in full culture medium. Cell Index
responses to e-liquid flavorings were recorded every
15 min for 24 h. Physiological responses to ATP and
forskolin were recorded every 30 s for 4 h following a
24 h exposure to select e-liquid flavorings. Cell re-
sponses were collected in triplicate or quadruplicate. To
better compare readings, cell responses were adjusted to
a baseline by taking the ratio of recordings from cells in
culture medium alone and then normalizing at the
time point of e-liquid flavoring or cell signaling agon-
ist addition as described in supplemental figure S2 in
[28]. E-liquid flavoring chemicals screened with high-
capacity real-time cell analysis were based on those
from popular brands such as blu and GreenSmoke®
e-cigarette cartridges with distinct organoleptic proper-
ties including: 2,5-dimethylpyarzine (chocolate, nutty
flavor); damascenone (apple, citrus, wine-like); linalool
(floral, spice); α-ionone (fruity, raspberry); ethyl maltol
(caramel); furaneol (strawberry, sweet); and vanillin
(vanilla) [29, 30].
MTS cytotoxicity assay
16HBE14o- cells were seeded on a tissue culture treated
96-well plate coated with CFB at a density of 40,000
cells/well. Cells were grown overnight and then treated
with e-liquid flavoring chemicals diluted in MEM.
Following a 24-h exposure to the e-liquid chemicals
cytotoxicity was assessed using a CellTiter 96® AQueous
Non-Radioactive Cell Proliferation Assay (MTS; Promega,
Madison, WI). MTS dye was added to all wells at a
1:10 dilution and allowed to incubate at 37 °C in 5 % CO2
for 1.5 h. The 96-well plate was then shaken vigorously
and read in a Synergy™ HTX Multi-Mode Microplate
Reader (BioTek, Winooski, VT) at an absorbance of
490 nm.
Ussing chamber studies
MTE cells on 6.5 mm permeable filters were mounted in
an EasyMount Ussing chamber system (Physiologic
Instruments, San Diego, CA) and bathed on both sides
with Krebs-Ringers Buffer containing: 115 mM NaCl,
25 mM NaHCO3, 0.4 mM KH2PO4, 2.4 mM K2HPO4,
1.2 mM CaCl2, and 1.2 mM MgCl2 with 10 mM glucose.
Bath solutions were continuously circulated with a gas
lift by bubbling with 95 % air and 5 % CO2 at 37 °C
(pH 7.4). MTE cell monolayers were voltage clamped
and monitored for changes in short-circuit current (Isc)
and TER with a multichannel voltage/current clamp
VCC MC8 (Physiologic Instruments, San Diego, CA).
MTE cell monolayers were clamped to 0 mV and a
5 mV pulse of 200-msec duration was imposed every
10 s. Changes in Isc (ΔIsc) were calculated from the dif-
ference between the initial Isc measurement at baseline
and the peak measurement change after adding 2,5-
dimethylpyrazine alone or in combination with pharma-
cological inhibitors/agonists. Data was analyzed using
Acquire and Analyze software, version 2.3 (Physiologic
Instruments, San Diego, CA).
Statistics
One-way ANOVA with a Dunnett’s Multiple Comparison
Test was used for statistical analysis unless otherwise
noted. A value of P < 0.05 was used to establish sig-
nificant differences between data sets. Figures are
graphed ± standard error of the mean (SEM) unless
otherwise noted.
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Results
High-capacity real-time cell analysis reveals toxicity
thresholds of e-liquid flavorings
Elucidating e-liquid flavorings that pose potential risks to
lung health is challenging given the vast array of available
flavoring chemical constituents. To address this barrier we
used high-capacity real-time cell analysis on a human bron-
chial epithelial cell line (16HBE14o) with multiple e-liquid
flavoring chemicals. We screened seven flavoring chemicals
present in e-liquid cartridges from popular e-cigarette
brands (i.e., Blu, GreenSmoke®) [29, 30]. Four of the flavor-
ings (Fig. 1a-d) were tested with the highest concentration
representing the percent volume/volume (% v/v) present in
GreenSmoke® e-cigarette cartridges and three flavorings
(Fig. 1e-g) were tested starting at a concentration one-tenth
(due to solubility issues) the % v/v present in GreenSmoke®
e-cigarette cartridges. All flavorings were screened at mul-
tiple concentrations in quadruplicate.
In five of the seven compounds tested the highest con-
centration(s) displayed a loss of cell index consistent
with cytotoxicity (Fig. 1a-e). We confirmed the loss of
cell index was due to cytotoxicity with an MTS assay. In
the MTS assay we compared those e-liquid chemical
concentrations that showed cytotoxicity in the RTCA
with the same flavor chemicals at a concentration that
did not display cytotoxicity in the RTCA (Fig. 1h).
Fig. 1 High-capacity real-time cellular analysis reveals toxicity thresholds of e-liquid flavorings. The toxicity thresholds of individual e-cigarette liquid
flavoring constituents on 16HBE14o- cells was determined by cellular impedance changes over 24 h. a-d The highest concentration of each flavoring
constituent was representative of the % v/v present in e-cigarette liquid. e-g The highest concentration of each flavoring constituent represented 1/
10th the % v/v present in e-cigarette liquid. All flavors except furaneol (f) and vanillin (g) displayed cell index changes consistent with cytotoxicity that
was validated with an MTS assay (h). *indicates significant difference from control cells and ^indicates significant difference between concentrations of
the same flavoring, P < 0.05 in a one-way ANOVA with a Tukey’s Multiple Comparison Test
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Furaneol (Fig. 1f ) and vanillin (Fig. 1g) did not display
any cell index changes consistent with cell death; how-
ever, the cell index for the full concentration present in
e-liquid for these compounds could not be tested due to
solubility issues. In addition to cytotoxicity responses at
the higher concentrations, at dilutions to one-tenth the
amount present in e-liquid, 2,5-dimethylpyrazine and
vanillin displayed increases in cell index consistent with
a cell-signaling event. Because of the unique combin-
ation of cytotoxicity and cellular signaling exhibited by
2,5-dimethylpyrazine we selected this compound from
the initial screen for further toxicity studies.
2,5-Dimethylpyrazine reduces the physiological response
to signaling molecules important in aspects of airway
epithelial cell innate immunity
We conducted a secondary high-capacity real-time cell
analysis screen of 2,5-dimethylpyrazine to examine in
finer detail the signaling pattern elicited by 16HBE14o-
cells upon exposure (Fig. 2a). Concentrations of 2,5-
dimethylpyrazine as low as 0.02 % v/v (1/100 of what is
in e-liquid) induced distinct cellular impedance changes
indicative of a cellular signaling event. Additionally, we
tested the capability of 16HBE14o- cells to respond to
cAMP (via forskolin) or exogenous ATP, important
signaling molecules in airway epithelial cell physiology
(e.g., mucociliary clearance), following exposure to
2,5-dimethylpyrazine (Fig. 2b-c). 16HBE14o- cells were
treated for 24 h with subcytotoxic concentrations of 2,5-
dimethylpyrazine followed by exposure to either forskolin
(10 μM; to raise cAMP) or exogenous ATP (3 μM; to raise
intracellular Ca2+ concentration) and cellular impedance
monitored. Compared to untreated cells, cells that were
treated for 24 h with 2,5-dimethylpyrazine displayed a
concentration-dependent reduction in physiological re-
sponse to both forskolin (Fig. 2b) and to ATP (Fig. 2c).
We concluded that 2,5-dimethylpyrazine alters the cap-
ability of airway epithelial cells to respond to signaling
molecules key in the proper functioning of airway cell
physiology.
2,5-Dimethylpyrazine increases airway epithelial ion
conductance
In order to determine the impact of 2,5-dimethylpyra-
zine on airway epithelial ion conductance and barrier
function we conducted Ussing chamber studies. Well-
differentiated primary mouse tracheal epithelial (MTE)
cells that retain characteristics such as polarization
needed for biophysical measurements were mounted in
Ussing chambers and voltage clamped for measurement
of ion conductance [short circuit current (Isc)] and trans-
epithelial resistance (TER). When administered in the
apical chamber (i.e., luminal side of the epithelium) 2,5-
dimethylpyrazine induced an apical ion efflux (Fig. 3a)
that was accompanied by a transient loss in TER
(Fig. 3c). Application of multiple concentrations of 2,5-
dimethylpyrazine resulted in an Isc EC50 ~ 1/100th of the
concentration found in GreenSmoke® e-liquid (Fig. 3b;
EC50 = 0.021 % v/v 95 % Confidence Interval: 0.0085 to
0.053 % v/v).
2,5-Dimethylpyrazine activates apical ion efflux via cystic
fibrosis transmembrane conductance regulator (CFTR)
It is known that 2,5-dimethylpyrazine is an odorant
compound found in dark chocolate [31]. Odorants can
Fig. 2 2,5-Dimethylpyrazine reduces the physiological response to
cellular signaling critical in airway innate immunity. a 16HBE14o- cells
display cytotoxic cellular impedance responses to 2,5-dimethylpyrazine
at 0.6 % and higher. b A 24 h exposure to subcytotoxic concentrations
of 2,5-dimethylpyrazine causes a concentration-dependent
signaling response to forskolin in 16HBE14o- cells. c A 24 h
exposure to subcytotoxic concentrations of 2,5-dimethylpyrazine
results in a reduction in 16HBE14o- signaling response to ATP.
At subcytotoxic concentrations, 2,5-dimethylpyrazine evoked a
physiological response at concentrations as low as 0.06 % v/v
and dampened the response to cellular signaling key in airway
epithelial innate immunity
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bind a class of G protein-coupled receptors that initiate
an adenylyl cyclase-signaling cascade [32, 33]. Since air-
way epithelial cells express CFTR on their apical surface
we tested the hypothesis that observed 2,5-dimethylpyra-
zine increases in Isc (Fig. 3) were due to CFTR-mediated
Cl- conductance resulting from increased levels of cAMP
downstream of odorant receptor activation. We con-
ducted Ussing chamber studies under voltage clamp
conditions with 0.2 % v/v 2,5-dimethylpyrazine, a subcy-
totoxic concentration that showed signaling activity in
high-capacity real-time cell analysis and Ussing chamber
studies, to evaluate the effects of pharmacological
blockers/agonists in the cAMP/CFTR signaling cascade.
In the first experiment, we pre-treated MTE cell cul-
tures with the epithelial sodium channel blocker amilor-
ide (10 μM; Fig. 4a-b dashed arrow) followed by apical
addition of CFTR blocker CFTR-172 inh (20 μM;
Fig. 4a-b dotted arrow). These cells were then exposed
to apical addition of 2,5-dimethylpyrazine (0.2 % v/v;
Fig. 4a-b solid arrow) while monitoring Isc and TER.
The peak change in Isc and TER evoked by 2,5-
dimethylpyrazine in MTE cells pre-treated with amiloride
and CFTR-172 inh (Fig. 4a-b dotted traces) was signifi-
cantly reduced [Fig. 4a-b; ΔIsc: 2.0 ± 0.46 μA/cm
2 (n = 4);
ΔTER: 67.6 ± 4.0 Ω ⋅ cm2 (n = 4)] compared to those
treated with only amiloride and 2,5-dimethylpyrazine
[Fig. 4a-b solid traces; ΔIsc: 7.7 ± 0.69 μA/cm
2 (n = 3);
ΔTER: 121.7 ± 27.6 Ω ⋅ cm2 (n = 3)].
In order to confirm that 2,5-dimethylpyrazine was act-
ing through a cAMP-protein kinase A (PKA) signaling
cascade, and not by directly activating CFTR, we used
the PKA blocker H89. MTE cells were monitored for re-
sponse to 2,5-dimethylpyrazine (0.2 % v/v; Fig. 5a-b solid
arrow) following a 30 min pre-treatment with H89
(10 μM) and amiloride (10 μM; Fig. 5a-b dashed arrow).
Representative Isc and TER traces (dotted lines) for the
blocking experiment are shown in Fig. 5a-b. The peak
change in Isc and TER evoked by 2,5-dimethylpyrazine
in MTE cells pretreated with H89 [(Fig. 5a-b; ΔIsc: 1.8 ±
0.12 μA/cm2 (n = 3); ΔTER: 53.7 ± 10.8 Ω ⋅ cm2 (n = 3)]
was significantly reduced compared to controls.
To test if an increase in intracellular cAMP concentra-
tion was necessary for the 2,5-dimethylpyrazine activation
of CFTR in MTE cells, we administered the cAMP analog
8-bromo-cAMP (100 μM; Fig. 6a-b dotted arrow) to MTE
cell cultures under current clamp conditions prior to the
addition of 2,5-dimethylpyrazine. Following 8-bromo-
cAMP addition, and upon Isc and TER stabilization, we
added amiloride (10 μM; Fig. 6a-b dashed arrow) and then
2,5-dimethypyrazine (0.2 % v/v; Fig. 6a-b solid arrow).
Representative Isc and TER traces (dotted lines) for this
experiment are shown in Fig. 6a-b. The peak change in Isc
and TER evoked by 2,5-dimethylpyrazine in MTE cells
pretreated with 8-bromo-cAMP and amiloride (Fig. 6a-b;
ΔIsc: 0.8 ± 0.05 μA/cm
2 (n = 3); ΔTER: 22.2 ± 4.8 Ω ⋅ cm2
(n = 3) was significantly reduced compared to controls.
The addition of intracellular 8-bromo-cAMP significantly
attenuated the changes in Isc and TER evoked by 2,5-
dimethylpyrazine, supporting the hypothesis that 2,5-
dimethylpyrazine leads to increased levels of cellular
cAMP to alter Isc. From these experiments we conclude
that 2,5-dimethylpyrazine increases apical Cl- efflux in pri-
mary airway epithelial cells via CFTR, and that activation
of CFTR is through a cAMP-PKA signaling cascade.
Discussion
In this study we used a high-capacity validated screen to
examine concentration-dependent cytotoxicity from seven
common e-cigarette flavorings in order to assess their
safety in the airway. In addition to identifying cytotoxicity
thresholds for five of the seven chemicals tested, we were
able to identify two compounds, 2,5-dimethylpyrazine and
Fig. 3 2,5-Dimethylpyrazine increases airway epithelial ion conductance. Primary MTE cells were voltage clamped in Ussing chambers and monitored for
changes in Isc and TER following varying doses of 2,5-dimethylpyrazine. a Representative traces of Isc in response to 2,5-dimethylpyrazine demonstrate a
concentration dependent increase in Isc. b A concentration-dependent curve of the change in Isc following 2,5-dimethylpyrazine. c Representative traces of
TER in response to varying concentrations of 2,5-dimethylpyrazine demonstrate a concentration dependent drop in TER. Addition of 2,5-dimethylpyrazine
on the apical airway epithelial surface results in an increase in apical ion efflux with a concurrent drop in TER
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vanillin, that significantly altered airway epithelial cellular
physiologic responses. Further characterization of 2,5-
dimethylpyrazine demonstrated a compromising effect on
the response to common airway epithelial cellular sig-
naling molecules in 16HBE14o- cells following a 24 h
exposure. In primary MTE cells it evoked a rapid ac-
tivation (min) of Cl- current through a cAMP/PKA/
CFTR-signaling pathway.
Early reports on e-cigarette toxicity focused primarily
on identifying constituents in e-cigarette liquids and aero-
sols that are known to be harmful in conventional
cigarettes (e.g., nicotine, tobacco-specific nitrosamines, al-
dehydes, volatile organic compounds) with less attention
given to unique additives such as vegetable glycerin, pro-
pylene glycol and flavorings (for reviews see [3, 34, 35]).
Limited studies on the pulmonary effects of short-term e-
cigarette use include increased airway resistance, de-
creased exhaled nitric oxide, and reported symptoms of
cough [36–38]. An important argument from these initial
studies is the emphasis for controlled research to properly
evaluate all components in e-cigarette aerosols and their
impact on lung cells and tissues. Careful studies that out-
line toxicity of flavorings are especially important consid-
ering that taste, including the large varieties of flavors, is a
key consideration that contributes to the use of e-
cigarettes [36]. In this study we employed a high-capacity
real-time cellular screening assay to identify those flavor-
ing additives that demonstrate the potential to cause harm
to the conducting airway epithelium. This high-capacity
acute-liquid exposure model offers a means to delineate
those flavoring constituents that are most detrimental
from the multitude of constituents on the market. Such
information can be used in future experiments that assess
chronic aerosol exposures in vitro and in vivo to assess
long-term effects.
Additives that allow for e-cigarette taste have been
discussed as potential health hazards [13]. For example,
an examination of flavoring constituents in 28 different
e-liquid products found the presence of 141 different
flavoring chemicals, some of which are known as al-
lergenic compounds (e.g., eugenol and cinnamic aldehyde)
[9]. An argument for the current use of flavorings in
Fig. 4 2,5-Dimethylpyrazine activates apical ion efflux via CFTR. Primary MTE cells were voltage clamped in Ussing chambers and monitored for
changes in Isc and TER following addition of 0.2 % v/v 2,5-dimethylpyrazine. a Representative traces of Isc and b TER (left) from MTE cells treated
with 2,5-dimethylpyrazine alone (solid line) or 2,5-dimethylpyrazine plus CFTR-172 inh [amiloride (dashed arrow), CFTR-172 inh (dotted arrow),
2,5-dimethylpyrazine (solid arrow)]. Quantification of Isc and TER (A-B right) of amiloride controls (n = 3) versus cells treated with amiloride and
CFTR-172 inh (n = 4) are graphed. The addition of CFTR-172 inh significantly reduced the 2,5-dimethypyrazine-evoked apical ion efflux suggesting
Cl− secretion via CFTR. *indicates significant difference P < 0.05 in a one-way ANOVA with a Dunnett’s Multiple Comparison Test
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e-liquids is their prior approval by regulatory agencies for
ingestion in small amounts. However, most chemicals
used in flavorings have not been tested for respiratory tox-
icity via the inhalation route [39] and implications that in-
gestion safety is comparable to inhalation safety is, at best,
misleading [40]. As an example, in the early 2000s several
workers at microwave popcorn packaging plants across
the U.S. developed bronchiolitis obliterans, a rare and irre-
versible obstructive lung disease that was later attributed
to the artificial butter flavoring component diacetyl [12].
Despite the known inhalation toxicity of diacetyl, an
examination of over 150 sweet flavored e-liquids found
that 69.2 % contained diacetyl in both the e-liquid and its
corresponding aerosol. Further, almost half (47.3 %) of
these e-liquids contained diacetyl at concentrations above
the National Institute for Occupational Safety and Health
(NIOSH) safety levels for occupational exposure [41]. It is
clear that a need for research to characterize both the
presence of toxic chemicals in e-cigarette flavorings and
the potential adverse respiratory effects of exposure to
those flavorings is needed [13]. The experimental setup in
this study aims to identify those flavoring chemicals that
disrupt airway epithelial function and the mechanisms by
which this disruption occurs.
It is becoming increasingly evident that constituents in
e-liquids can compromise various aspects of airway
epithelial innate immunity. In the absence of nicotine,
e-liquids caused increased pro-inflammatory cytokines
(e.g., IL-6) and increased human rhinovirus infection
in primary human airway epithelial cells [42]. In a
separate study, e-liquids containing flavorings, espe-
cially those with fruit or sweet flavors, were more
oxidative than those without flavorings, and thus po-
tentially more damaging to the airway [43]. These au-
thors also found that e-liquid aerosols increased
secretion of IL-6 and IL-8 from human airway epithelial
cells grown at an air/liquid interface. Our studies using
high-capacity real-time cell analysis show the e-liquid
chemical 2,5-dimethylpyrazine reduces the ability of
16HBE14o- cells to respond to forskolin-induced cAMP
signaling and to a lesser extent exogenous ATP at subcy-
totoxic concentrations. These signaling pathways underlie
Fig. 5 PKA signaling is upstream of 2,5-dimethylpyrazine-evoked apical ion efflux. Primary MTE cells were voltage clamped in Ussing chambers and
monitored for changes in Isc and TER following addition of 0.2 % v/v 2,5-dimethylpyrazine. a Representative traces of Isc and b TER (left) from MTE cells
pre-treated with H-89 followed by amiloride (dashed arrow) and 2,5-dimethylpyrazine (solid arrow). Quantification of Isc and TER (A-B right) of amiloride
controls (n = 3) versus cells treated with amiloride and H89 (n = 3) are graphed. Significant block of apical ion efflux with H89 suggests
2,5-dimethypyrazine-evoked apical ion efflux is mediated via PKA signaling. *indicates significant difference P < 0.05 in a one-way ANOVA
with a Dunnett’s Multiple Comparison Test
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several important physiological functions in the conduct-
ing airway epithelium.
Our biophysical studies are indicative of an acute 2,5-
dimethylpyrazine-evoked cAMP/PKA-signaling pathway
that is consistent with the activation of an odorant re-
ceptor. Odorant receptors are not restricted to the upper
airway and can have distinct physiologic function within
the conducting airway as well as in other parts of the
body (reviewed in [44]). 2,5-dimethylpyrazine is also a
potent pheromone in both Drosophila [45] and in mice
where it can lead to suppression of reproductive activ-
ities (reviewed in [46]). In this study we show that 2,5-
dimethylpyrazine activates cAMP/PKA signaling leading
to transient changes in short-circuit current and transe-
pithelial resistance via CFTR in mouse conducting
airway epithelial cells. Chronic activation of CFTR sig-
naling in vivo may alter CFTR expression and salt and
water balance in the airway lumen that could negatively
impact airway epithelial cell innate immune mechanisms
such as mucociliary clearance.
Conclusions
E-cigarettes have become a common way to introduce
flavorings via inhalation with unknown long-term
health effects. It is established that flavored conven-
tional cigarettes are more appealing among youth;
17 year olds three times more likely than 25 year olds
to smoke a flavored cigarette [47]. Because of such
findings, the 2009 Family Smoking Prevention and
Tobacco Control Act banned flavored conventional
cigarettes (excepting menthol and tobacco flavor) in
an effort to reduce the number of young adults who
become addicted to cigarettes [48]. The recent intro-
duction of ENDS, including e-cigarettes has provided
an avenue to re-introduce flavorings to inhalation de-
vices. With the multitude of e-cigarette flavoring
choices in the marketplace it is essential that the con-
stituents comprising these flavorings be assessed for
human safety in order to inform regulatory authorities,
healthcare providers and most importantly, e-cigarette
users. Our approach to screen constituents for both
Fig. 6 Increased intracellular cAMP dampens 2,5-dimethylpyrazine-evoked apical ion efflux. Primary MTE cells were voltage clamped in
Ussing chambers and monitored for changes in Isc and TER following addition of 0.2 % v/v 2,5-dimethylpyrazine. a Representative traces
of Isc and b TER (left) from MTE cells pre-treated with 8-bromo-cAMP (dotted arrow) followed by amiloride (dashed arrow) and 2,5-
dimethylpyrazine (solid arrow). Quantification of Isc and TER (A-B right) of amiloride controls (n = 3) versus cells treated with 8-bromo-
cAMP and amiloride (n = 3) are plotted. The addition of the cAMP analog 8-bromo-cAMP significantly reduced apical ion efflux evoked by
2,5-dimethypyrazine suggesting it activates a receptor that increases cAMP production. *indicates significant difference P < 0.05 in a one-
way ANOVA with a Dunnett’s Multiple Comparison Test
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cytotoxicity and subcytotoxic alterations in conducting
airway epithelial cell physiology, followed by mechanistic
studies, provides a successful strategy for understanding
potential toxicants commonly used in e-cigarettes and
other ENDS.
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